BioWorld

Feb. 18, 2003

Neose Secures $17M Privately To Advance Internal Programs

Neose Technologies Inc. is raising $17 million through a private placement of common stock. The Horsham, Pa.-based company said late Thursday it entered into a definitive agreement to sell about 2.9 million common shares for $6 apiece. (BioWorld Today) Read More

GSK's Decision To Limit Sales Rankles Some Representatives

By Walling Off Cyanide, Scientists Seek Pollution-Free Hydrogen Fuel For Industry, Medical Applications

Vertex, GSK Present Preliminary Results From Two Pivotal Trials

Holiday Notice

BioWorld's offices were closed Monday in observance of the Presidents Day holiday in the U.S. No issue was published that day. Read More

Dolly, A Symbol Of Biotech, Dies At 6 From Lung Disease

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for April 20, 2026.

Man holding raised arm with illustrated overlay of nerves

Biohaven reports details on discovery of BHV-2100

BioWorld Science

Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...

Elderly woman holding illustration of brain with missing puzzle piece

Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

BioWorld

The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...

New GABA(B) receptor PAMs revealed in Addex Pharma patents

BioWorld Science

Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...

Novel caspase-2 inhibitor shows in vivo neuroprotective effects

BioWorld Science

Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...